BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11217818)

  • 1. A case report of olanzapine-induced hypersensitivity syndrome.
    Raz A; Bergman R; Eilam O; Yungerman T; Hayek T
    Am J Med Sci; 2001 Feb; 321(2):156-8. PubMed ID: 11217818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pustular eruption induced by olanzapine, a novel antipsychotic agent.
    Adams BB; Mutasim DF
    J Am Acad Dermatol; 1999 Nov; 41(5 Pt 2):851-3. PubMed ID: 10534668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical neuroleptic malignant syndrome associated with olanzapine.
    Reeves RR; Torres RA; Liberto V; Hart RH
    Pharmacotherapy; 2002 May; 22(5):641-4. PubMed ID: 12013364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tardive dystonia associated with olanzapine therapy.
    Gunal DI; Onultan O; Afsar N; Aktan S
    Neurol Sci; 2001 Aug; 22(4):331-2. PubMed ID: 11808858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topiramate produced weight loss following olanzapine-induced weight gain in schizophrenia.
    Levy E; Margolese HC; Chouinard G
    J Clin Psychiatry; 2002 Nov; 63(11):1045. PubMed ID: 12469686
    [No Abstract]   [Full Text] [Related]  

  • 6. Valproic Acid-related anticonvulsant hypersensitivity syndrome and subsequent olanzapine-related neutropenia and thrombocytopenia: a case report.
    Lin YH; Chien YL
    J Clin Psychopharmacol; 2012 Feb; 32(1):132-3. PubMed ID: 22217947
    [No Abstract]   [Full Text] [Related]  

  • 7. Olanzapine-induced neuroleptic malignant syndrome.
    Burkhard PR; Vingerhoets FJ; Alberque C; Landis T
    Arch Gen Psychiatry; 1999 Jan; 56(1):101-2. PubMed ID: 9892264
    [No Abstract]   [Full Text] [Related]  

  • 8. Olanzapine-induced respiratory failure.
    Mouallem M; Wolf I
    Am J Geriatr Psychiatry; 2001; 9(3):304-5. PubMed ID: 11481140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case report of withdrawal syndrome after olanzapine discontinuation.
    Nayudu SK; Scheftner WA
    J Clin Psychopharmacol; 2000 Aug; 20(4):489-90. PubMed ID: 10917413
    [No Abstract]   [Full Text] [Related]  

  • 10. Case report: possible neuroleptic malignant syndrome associated with olanzapine.
    Moltz DA; Coeytaux RR
    J Clin Psychopharmacol; 1998 Dec; 18(6):485-6. PubMed ID: 9864084
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute hepatocellular-cholestatic liver injury after olanzapine therapy.
    Jadallah KA; Limauro DL; Colatrella AM
    Ann Intern Med; 2003 Feb; 138(4):357-8. PubMed ID: 12585842
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug rash with eosinophilia and systemic symptoms (DRESS) attributed to the oral skin-care supplement Imedeen].
    van Leeuwen JF; van der Hooft CS; Vos LE; Bekkenk MW; van Zuuren EJ; Stricker BH
    Ned Tijdschr Geneeskd; 2005 Jun; 149(24):1353-6. PubMed ID: 16008041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propranolol treatment of olanzapine-induced akathisia.
    Kurzthaler I; Hummer M; Kohl C; Miller C; Fleischhacker WW
    Am J Psychiatry; 1997 Sep; 154(9):1316. PubMed ID: 9286196
    [No Abstract]   [Full Text] [Related]  

  • 14. [Neuroleptic malignant syndrome associated with olanzapine].
    García López MM; Ciprés L; de Cendra E; Vilalta Franch J
    Med Clin (Barc); 1999 Sep; 113(6):239. PubMed ID: 10472615
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mnestic impairment under olanzapine overdosage in an elderly patient].
    Grieshaber S; Jatzko A; Adler G
    Psychiatr Prax; 2002 Nov; 29(8):441-4. PubMed ID: 12436366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe episode of high fever with rash, lymphadenopathy, neutropenia, and eosinophilia after minocycline therapy for acne.
    Kaufmann D; Pichler W; Beer JH
    Arch Intern Med; 1994 Sep; 154(17):1983-4. PubMed ID: 8074603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mexiletine-induced severe skin eruption, fever, eosinophilia, atypical lymphocytosis, and liver dysfunction.
    Higa K; Hirata K; Dan K
    Pain; 1997 Oct; 73(1):97-9. PubMed ID: 9414061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenytoin-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a case report from the emergency department.
    Oelze LL; Pillow MT
    J Emerg Med; 2013 Jan; 44(1):75-8. PubMed ID: 21852061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe hypertriglyceridemia associated with olanzapine.
    Stoner SC; Dubisar BM; Khan R; Farrar CD
    J Clin Psychiatry; 2002 Oct; 63(10):948-9. PubMed ID: 12416606
    [No Abstract]   [Full Text] [Related]  

  • 20. Olanzapine-induced neutropenia.
    Gajwani P; Tesar GE
    Psychosomatics; 2000; 41(2):150-1. PubMed ID: 10749954
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.